본문

서브메뉴

상세정보

Applications of Synthetic Biology for Emerging Biotechnology- [electronic resource]
Applications of Synthetic Biology for Emerging Biotechnology - [electronic resource] / Mic...
Applications of Synthetic Biology for Emerging Biotechnology- [electronic resource]

상세정보

자료유형  
 학위논문(국외)
자관 청구기호  
기본표목-개인명  
표제와 책임표시사항  
Applications of Synthetic Biology for Emerging Biotechnology - [electronic resource] / Michael S. Belcher
발행, 배포, 간사 사항  
발행, 배포, 간사 사항  
Ann Arbor : ProQuest Dissertations & Theses , 2022
    형태사항  
    1 online resource(p.86 )
    일반주기  
    Source: Dissertations Abstracts International, Volume: 85-04, Section: B.
    일반주기  
    Advisor: Keasling, Jay;Scheller, Henrick.
    학위논문주기  
    Thesis (Ph.D.)--University of California, Berkeley, 2022.
    이용제한주기  
    This item must not be sold to any third party vendors.
    요약 등 주기  
    요약As government and corporate policies transition to meet the UNs sustainable development goals as outlined in Agenda 2030, there will be a drastic need for the invention and refinement of "green technologies" applicable in a variety of economic sectors and disciplines. Biotechnology has become heavily influenced by the field of synthetic biology, which offers the capacity to deconstruct, shape, and rebuild natural systems from all domains of life. This is achieved via the development and integration of novel synthetic systems with natural biological processes. The potential of synthetic biology is now being realized as demonstrated by its application in numerous industries including (but not limited to): medicine, agriculture, food, energy (both bio and petroleum based), natural product discovery and production, pharmaceutical drug development, and materials science. Tools such as CRISPR-Cas9, along with the development of next generation DNA synthesis, assembly, and sequencing technologies, have unlocked the potential of synthetic biology. This has made the engineering and augmentation of most living systems possible, allowing for the development of complex and refined genetically modified organisms (GMOs) for deployment in numerous applications. The world is transitioning into the era of the Fourth Industrial Revolution, an era focused on the mitigation of climate change and the race to Net Zero. I envision that synthetic biology will play a crucial role in this transition, and while this space is much too vast for one person to explore in totality, scientists continue to work on independent components while exploring collaboration for the synergistic application of their discoveries. Eventually, the input from varying specialties form functional "high-level" systems developed with synthetic biology. In particular, the fields of synthetic plant biology and synthetic yeast biology have shown great promise for the development of breakthrough biotechnology platforms. The engineering of plants that serve as primary feedstocks for biofuel production (which generally has focused on maximizing the feedstock-to-fuel conversion efficiency through cell wall engineering) is now exploring the augmentation of current agricultural systems for the bioproduction of high-value biologics and therapeutics in planta. While still nascent in application, there is much promise for these technologies due to the scalability of in planta production, without the need for sterile conditions or complex manufacturing controls. The development of more efficient and versatile methods for the engineering of synthetic genetic circuits in plants is crucial for the deployment of the highly specialized plant chassis in biotechnological settings. Yeast, on the other hand, can serve as a counterpart to large-scale bioproduction in plants by providing a chassis for biochemical pathway discovery and complete biosynthesis of complex molecules from all domains of life. Yeast is a highly dynamic single-celled eukaryotic organism that has been highly characterized and is easily manipulated/engineered in the lab. In recent decades yeast has proven to be an effective platform for the bioproduction of various natural, specialty, and commodity chemicals whose manufacturing is not possible or cost effective with current methods. Additionally, yeast as a bioproduction platform offers the prospective of new-to-nature molecules through the coalescing of biosynthetic enzymes from disparate pathways. This is a truly exciting prospect for the future of drug discovery and development as we utilize the vast genetic diversity of the biological world for the construction of novel biosynthetic enzymes and pathways. The following sections aim to highlight my research focused on synthetic plant and yeast biology, with a focus on the development of technologies and strategies for application in the bioenergy and bioproduction sectors. While this alone will not answer all the existential problems of a transitioning world, it represents a small piece of a very large puzzle that we as a collective are working to solve.
    주제명부출표목-일반주제명  
    주제명부출표목-일반주제명  
    주제명부출표목-일반주제명  
    비통제 색인어  
    비통제 색인어  
    비통제 색인어  
    비통제 색인어  
    비통제 색인어  
    부출표목-단체명  
    기본자료저록  
    Dissertations Abstracts International. 85-04B.
    기본자료저록  
    Dissertation Abstract International
    전자적 위치 및 접속  
     원문정보보기
    소장사항  
    202402 2024

    MARC

     008240306s2022        s  |          s        0000c|  eng  d
    ■001000016931880
    ■00520240214100321
    ■006m          o    d                
    ■007cr
    ■020    ▼a9798380619622
    ■035    ▼a(MiAaPQ)AAI30246011
    ■040    ▼aMiAaPQ▼cMiAaPQ
    ■08204▼a610
    ■090    ▼a전자도서(박사논문)
    ■1001  ▼aBelcher,  Michael  S.
    ■24510▼aApplications  of  Synthetic  Biology  for  Emerging  Biotechnology▼h[electronic  resource]▼cMichael  S.  Belcher
    ■260    ▼a[S.l.]▼bUniversity  of  California,  Berkeley.  ▼c2022
    ■260  1▼aAnn  Arbor▼bProQuest  Dissertations  &  Theses▼c2022
    ■300    ▼a1  online  resource(p.86  )
    ■500    ▼aSource:  Dissertations  Abstracts  International,  Volume:  85-04,  Section:  B.
    ■500    ▼aAdvisor:  Keasling,  Jay;Scheller,  Henrick.
    ■5021  ▼aThesis  (Ph.D.)--University  of  California,  Berkeley,  2022.
    ■506    ▼aThis  item  must  not  be  sold  to  any  third  party  vendors.
    ■520    ▼aAs  government  and  corporate  policies  transition  to  meet  the  UNs  sustainable  development  goals  as  outlined  in  Agenda  2030,  there  will  be  a  drastic  need  for  the  invention  and  refinement  of  "green  technologies"  applicable  in  a  variety  of  economic  sectors  and  disciplines.  Biotechnology  has  become  heavily  influenced  by  the  field  of  synthetic  biology,  which  offers  the  capacity  to  deconstruct,  shape,  and  rebuild  natural  systems  from  all  domains  of  life.  This  is  achieved  via  the  development  and  integration  of  novel  synthetic  systems  with  natural  biological  processes.  The  potential  of  synthetic  biology  is  now  being  realized  as  demonstrated  by  its  application  in  numerous  industries  including  (but  not  limited  to):  medicine,  agriculture,  food,  energy  (both  bio  and  petroleum  based),  natural  product  discovery  and  production,  pharmaceutical  drug  development,  and  materials  science. Tools  such  as  CRISPR-Cas9,  along  with  the  development  of  next  generation  DNA  synthesis,  assembly,  and  sequencing  technologies,  have  unlocked  the  potential  of  synthetic  biology.  This  has  made  the  engineering  and  augmentation  of  most  living  systems  possible,  allowing  for  the  development  of  complex  and  refined  genetically  modified  organisms  (GMOs)  for  deployment  in  numerous  applications.  The  world  is  transitioning  into  the  era  of  the  Fourth  Industrial  Revolution,  an  era  focused  on  the  mitigation  of  climate  change  and  the  race  to  Net  Zero.  I  envision  that  synthetic  biology  will  play  a  crucial  role  in  this  transition,  and  while  this  space  is  much  too  vast  for  one  person  to  explore  in  totality,  scientists  continue  to  work  on  independent  components  while  exploring  collaboration  for  the  synergistic  application  of  their  discoveries.  Eventually,  the  input  from  varying  specialties  form  functional  "high-level"  systems  developed  with  synthetic  biology. In  particular,  the  fields  of  synthetic  plant  biology  and  synthetic  yeast  biology  have  shown  great  promise  for  the  development  of  breakthrough  biotechnology  platforms.  The  engineering  of  plants  that  serve  as  primary  feedstocks  for  biofuel  production  (which  generally  has  focused  on  maximizing  the  feedstock-to-fuel  conversion  efficiency  through  cell  wall  engineering)  is  now  exploring  the  augmentation  of  current  agricultural  systems  for  the  bioproduction  of  high-value  biologics  and  therapeutics  in  planta.  While  still  nascent  in  application,  there  is  much  promise  for  these  technologies  due  to  the  scalability  of  in  planta  production,  without  the  need  for  sterile  conditions  or  complex  manufacturing  controls.  The  development  of  more  efficient  and  versatile methods  for  the  engineering  of  synthetic  genetic  circuits  in  plants  is  crucial  for  the  deployment  of  the  highly  specialized  plant  chassis  in  biotechnological  settings. Yeast,  on  the  other  hand,  can  serve  as  a  counterpart  to  large-scale  bioproduction  in  plants  by  providing  a  chassis  for  biochemical  pathway  discovery  and  complete  biosynthesis  of  complex  molecules  from  all  domains  of  life.  Yeast  is  a  highly  dynamic  single-celled  eukaryotic  organism  that  has  been  highly  characterized  and  is  easily  manipulated/engineered  in  the  lab.  In  recent  decades  yeast  has  proven  to  be  an  effective  platform  for  the  bioproduction  of  various  natural,  specialty,  and  commodity  chemicals  whose  manufacturing  is  not  possible  or  cost  effective  with  current  methods.  Additionally,  yeast  as  a  bioproduction  platform  offers  the  prospective  of  new-to-nature  molecules  through  the  coalescing  of  biosynthetic  enzymes  from  disparate  pathways.  This  is  a  truly  exciting  prospect  for  the  future  of  drug  discovery  and  development  as  we  utilize  the  vast  genetic  diversity  of  the  biological  world  for  the  construction  of  novel  biosynthetic  enzymes  and  pathways. The  following  sections  aim  to  highlight  my  research  focused  on  synthetic  plant  and  yeast  biology,  with  a  focus  on  the  development  of  technologies  and  strategies  for  application  in  the  bioenergy  and  bioproduction  sectors.  While  this  alone  will  not  answer  all  the  existential  problems  of  a  transitioning  world,  it  represents  a  small  piece  of  a  very  large  puzzle  that  we  as  a  collective  are  working  to  solve. 
    ■590    ▼aSchool  code:  0028.
    ■650  4▼aBioengineering.
    ■650  4▼aPlant  sciences.
    ■650  4▼aBiochemistry.
    ■653    ▼aEmerging  biotechnology
    ■653    ▼aSynthetic  biology
    ■653    ▼aPlant  biology
    ■653    ▼aBiofuel  production
    ■653    ▼aGenetically  modified  organisms
    ■690    ▼a0202
    ■690    ▼a0479
    ■690    ▼a0487
    ■71020▼aUniversity  of  California,  Berkeley▼bPlant  Biology.
    ■7730  ▼tDissertations  Abstracts  International▼g85-04B.
    ■773    ▼tDissertation  Abstract  International
    ■790    ▼a0028
    ■791    ▼aPh.D.
    ■792    ▼a2022
    ■793    ▼aEnglish
    ■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T16931880▼nKERIS▼z이  자료의  원문은  한국교육학술정보원에서  제공합니다.
    ■980    ▼a202402▼f2024

    미리보기

    내보내기

    chatGPT토론

    Ai 추천 관련 도서


      신착도서 더보기
      관련도서 더보기
      최근 3년간 통계입니다.
      SMS 발송 간략정보 이동 상세정보출력

      소장정보

      • 예약
      • 서가에 없는 책 신고
      • 자료배달서비스
      • 나의폴더
      • 우선정리요청
      소장자료
      등록번호 청구기호 소장처 대출가능여부 대출정보
      EM164033 TD  전자도서(박사논문) 연속간행물실(2층) 온라인이용가능 온라인이용가능
      마이폴더

      * 대출중인 자료에 한하여 예약이 가능합니다. 예약을 원하시면 예약버튼을 클릭하십시오.

      해당 도서를 다른 이용자가 함께 대출한 도서

      관련도서

      관련 인기도서

      서평쓰기

      도서위치

      AiBot !!
      CH